ADL
GWPH

Asset Dedication LLC’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Asset Dedication LLC’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed – – 886
2021
Q1 		$0 Hold
1
– – ﹤0.01% 810
2020
Q4 		$0 Hold
1
– – ﹤0.01% 828
2020
Q3 		$0 Sell
1
-400
-100% -$46K ﹤0.01% 803
2020
Q2 		$49K Hold
401
– – 0.01% 319
2020
Q1 		$35K Hold
401
– – 0.01% 348
2019
Q4 		$42K Sell
401
-592
-60% -$66.4K 0.01% 315
2019
Q3 		$114K Buy
993
+1
+0.1% +$152 0.04% 214
2019
Q2 		$171K Hold
992
– – 0.06% 173
2019
Q1 		$167K Buy
+992
New +$148K 0.06% 163

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Asset Dedication LLC's GWPH Position: Q2 2021 in Review

Asset Dedication LLC sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1 share.

Asset Dedication LLC first reported a position in GWPH in Q1 2019 and held it in 9 quarters. The position peaked at $171K in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Asset Dedication LLC reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Asset Dedication LLC sold 1 GW Pharmaceuticals Plc American Depositary Shares share in Q2 2021.
  • Asset Dedication LLC first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 9 quarters.
  • Asset Dedication LLC's GW Pharmaceuticals Plc American Depositary Shares position peaked at $171K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Asset Dedication LLC's 13F filing for Q2 2021, filed 21 Jul 2021.